on 19 Feb 2025
Last Applicant/ Owned by
Vir Biotechnology, Inc.
1800 Owens Street, Suite 900San Francisco CA 94158
US
Serial Number
2381161 filed on 13th Jan 2025
Correspondent Address
SMART & BIGGAR LP
Scotia Plaza, 40 King Street West40th FloorToronto
ONTARIO
CA
M5H3Y2
Trademark usage description
antiviral pharmaceuticals; immunotherapy pharmaceuticals; antiviral pharmaceuticals for use in the treatment of infectious diseases and disorders and Read MoreVienna Information
2 . 1 . 23
Men stylized -- Note: Including stick figures of men.Hommes stylisés -- Note: Y compris les bonshommes-allumettes d'hommes.
2 . 1 . 30
Other menAutres hommes
4 . 5 . 2
Personified objects, combinations of objects representing a personageObjets personnifiés, assemblages d'objets représentant un personnage
4 . 5 . 3
Personified geometrical figures or solids, combinations of geometrical figures or solids representing a personageFigures ou corps géométriques personnifiés, assemblages de figures ou de corps géométriques représentant un personnage
9 . 1 . 10
Ribbons, bowsRubans, noeuds
26 . 1 . 1
CirclesCercles
26 . 1 . 3
One circle or ellipseUn cercle ou une ellipse
26 . 1 . 24
Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée
26 . 7 . 4
Circles or ellipses with lines (except 26.7.3)Cercles ou ellipses avec lignes (excepté 26.7.3)
26 . 11 . 2
Two lines or bandsDeux lignes ou bandes
26 . 11 . 6
Thick lines, bandsLignes épaisses, bandes
26 . 11 . 12
Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)
12
12
2381161
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 48 on 21st Mar 2025 | Agent Changed |
Submitted for opposition 257 on 20th Feb 2025 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 19th Feb 2025 | Created |
Submitted for opposition 31 on 19th Feb 2025 | Formalized |
Submitted for opposition 228 on 13th Jan 2025 | International Registration |
Submitted for opposition 30 on 13th Jan 2025 | Filed |